The world's first double hand transplant for scleroderma, performed on Steven Gallagher in Leeds, has been a success.
Whilst this is a drastic procedure, which won't be suitable for most people with scleroderma, it does underline the importance of finding new and innovative ways to treat and care for people with the condition so they can live well.
As well as giving Steven back range of motion in his hands, the operation will allow clinicians to monitor his condition over the coming years to see whether scleroderma will affect his new hands

This is an IDEAL opportunity to have YOUR say and be heard by our politicians.

The Australian health and medical research sector is at a crisis point due to over a decade of inadequate investment in the National Health and Medical Research Council (NHMRC). Please join our campaign to put health and medical research funding firmly on the political agenda by completing your details below to auto-generate an email to your Federal Electoral candidates.  

​It will take you less than one minute but will put our political leaders on notice that more investment in health and medical research is urgently needed to secure a healthy future for all Australians. ​

Can you imagine how it would impact life with SSc if we had a way to accurately predict whether or not Raynaud's was a warning sign for the condition?

​New research suggests that using the VEDOSS criteria could do just that - allowing for earlier diagnosis and potentially even the use of stratified medicine down the line.

An interesting perspective of being a middle child and feeling "different" until she was formally diagnosed with systemic scleroderma in 2001 at the age of 19. Read how her journey turned her siblings from feeling like "enemies" to now being her best supporters.